Published in Coron Artery Dis on June 01, 1996
Population pharmacokinetics and pharmacodynamics of bivalirudin in young healthy Chinese volunteers. Acta Pharmacol Sin (2012) 0.79
Selective in vitro growth of T lymphocytes from normal human bone marrows. Science (1976) 15.73
The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med (1992) 6.41
Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood (1979) 6.01
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation (1987) 5.73
The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med (1992) 3.53
Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. Science (1984) 3.20
The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med (1992) 3.16
Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis. J Am Coll Cardiol (1997) 3.06
Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A (1999) 2.98
HIV/HTLV gene nomenclature. Nature (1988) 2.72
Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation (2001) 2.41
Association of human T lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy. Am J Med (1986) 2.33
Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol (1990) 2.30
Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation (2000) 2.29
Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation (1995) 2.29
Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation (1990) 2.01
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol (1987) 1.99
Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation (1999) 1.94
Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation (1998) 1.94
Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest (1996) 1.92
Cardiovascular disease in women. Circulation (1993) 1.87
Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med (1984) 1.85
A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med (1982) 1.82
Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol (2000) 1.81
Complications of cardiac catheterization in the current era: a single-center experience. Catheter Cardiovasc Interv (2001) 1.72
Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood (2000) 1.59
Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment. Proc Natl Acad Sci U S A (1992) 1.59
Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation (1990) 1.57
Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation (2001) 1.54
Prevention of restenosis after angioplasty in small coronary arteries with probucol. Circulation (1998) 1.51
Insights into the pathogenesis of acute ischemic syndromes. Circulation (1988) 1.50
Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy. Circulation (1981) 1.49
Refractory prinzmetal angina treated with cyproheptadine. Ann Intern Med (1994) 1.48
Atrial fibrillation--risk marker for stroke. N Engl J Med (1990) 1.46
Acute coronary syndromes: biology. Lancet (1999) 1.46
Flavone-8-acetic acid (Flavonoid) profoundly reduces platelet-dependent thrombosis and vasoconstriction after deep arterial injury In vivo. Circulation (2000) 1.45
Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol (1983) 1.45
The effect of pimecrolimus on innate immunity in subjects with atopic dermatitis: a double-blind, randomized, vehicle-controlled study. Br J Dermatol (2012) 1.42
Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res (1985) 1.42
The challenge of valve surgery in a developing population. J Heart Valve Dis (1993) 1.40
A randomly amplified polymorphic DNA marker specific for the Bacillus cereus group is diagnostic for Bacillus anthracis. Appl Environ Microbiol (1999) 1.40
Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation (1997) 1.39
Repetitive structure in the long-terminal-repeat element of a type II human T-cell leukemia virus. Proc Natl Acad Sci U S A (1984) 1.39
Coronary excimer laser angioplasty: reduced complications and indium-111 platelet accumulation compared with thermal laser angioplasty. J Am Coll Cardiol (1990) 1.39
Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1. J Endocrinol Invest (2003) 1.39
Accelerated degeneration of aortic homograft in an infant. J Thorac Cardiovasc Surg (1994) 1.39
The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis (2000) 1.38
The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler Thromb Vasc Biol (1999) 1.37
Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol (1994) 1.37
Testing platelet activation with a shear-dependent platelet function test versus aggregation-based tests: relevance for monitoring long-term glycoprotein IIb/IIIa inhibition. Circulation (2001) 1.35
In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation (2000) 1.35
A dilemma for the 1990s. Choosing appropriate experimental animal model for the prevention of restenosis. Circulation (1992) 1.34
Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile. J Am Coll Cardiol (1999) 1.33
Molecular evolution of nitrogen fixation: the evolutionary history of the nifD, nifK, nifE, and nifN genes. J Mol Evol (2000) 1.30
Nomenclature of eukaryotic DNA polymerases. Science (1975) 1.30
Echocardiographic "smoke" is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces. J Am Coll Cardiol (1992) 1.24
Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med (2001) 1.24
Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med (1997) 1.23
Complete occlusion of the left main coronary artery and the importance of coronary collateral circulation. Mayo Clin Proc (1977) 1.22
Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. Circulation (1986) 1.21
Nomenclature of eukaryotic DNA polymerases. Eur J Biochem (1975) 1.20
Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation (1989) 1.19
Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. J Am Coll Cardiol (1995) 1.18
Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay. J Thromb Haemost (2009) 1.16
Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model. Arteriosclerosis (1986) 1.15
Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets. Circulation (1994) 1.12
Preferential stimulation of rabbit alpha globin mRNA translation by a cap-binding protein complex. Biochim Biophys Acta (1984) 1.12
Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii. Proc Natl Acad Sci U S A (1986) 1.11
Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation (1989) 1.11
Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation (2001) 1.10
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib. Ann Rheum Dis (2007) 1.09
The case for a family of reverse transcriptase viruses: Retraviridae. Intervirology (1974) 1.09
Aortic valve replacement with freehand autologous pericardium. J Thorac Cardiovasc Surg (1995) 1.08
Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. N Engl J Med (1984) 1.08
Coronary atherosclerosis. A multifactorial disease. Circulation (1993) 1.08
Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. Atherosclerosis (2000) 1.08
Effects of dietary supplementation with cod-liver oil on endothelium-dependent responses in porcine coronary arteries. Circulation (1987) 1.07
Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. J Am Coll Cardiol (1985) 1.07
Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders. Blood (1985) 1.07
Nitrogen fixation genes in an endosymbiotic Burkholderia strain. Appl Environ Microbiol (2001) 1.06
Effect of p27 deficiency and rapamycin on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model. Lab Invest (2001) 1.05
Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. J Am Coll Cardiol (1985) 1.05
HDL-induced prostacyclin release in smooth muscle cells is dependent on cyclooxygenase-2 (Cox-2). Arterioscler Thromb Vasc Biol (1997) 1.05
Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. Circulation (1986) 1.05
Plaque rupture, thrombosis, and therapeutic implications. Haemostasis (1996) 1.04
High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol (1995) 1.03
The vacuum cleft sign: an uncommon radiological sign. Osteoporos Int (2005) 1.03